JBS Forms $2.5B Protein JV with Indonesia's Sovereign Wealth Fund
JBS sits 21% above its 52-week low of $11.49.
Summary
JBS is contributing its Australia and New Zealand businesses to a joint venture with PT Danantara, an arm of Indonesia's sovereign wealth fund, which will invest $2.5 billion. The venture plans to raise an additional $2.5 billion in debt and targets an eventual IPO. This follows a tough period for JBS, including a 56% Q1 profit drop, China import suspensions, and a U.S. plant closure. The deal provides a capital infusion and a growth platform in Southeast Asia, potentially offsetting headwinds in other markets. The initial $800 million payment at closing and the five-year lock-up signal long-term commitment from both sides.
At the time of this announcement, JBS was trading at $13.93 on NYSE in the Trade & Services sector, with a market capitalization of approximately $14.6B. The 52-week trading range was $11.49 to $18.65. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.